Reference
Shimada M, et al. A successful pembrolizumab treatment case of lung adenocarcinoma after becoming resistant to ALK-TKI treatment due to G1202R mutation. Respiratory Investigation 56: 365-368, No. 4, Jul 2018. Available from: URL: http://doi.org/10.1016/j.resinv.2018.04.004 - Japan
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1713, 37 (2018). https://doi.org/10.1007/s40278-018-49871-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-49871-5